You are here: Industry Insights > AstraZeneca

News List

AstraZeneca’s first vaccine dose cuts Covid transmission by 67 per cent: Study expresspharma
February 05, 2021
The UK government described this as good news for the world because the impact of COVID vaccines on transmission has been a crucial unknown in the fight against the pandemic.
Malaysia sets February 2022 target to complete COVID-19 vaccine rollout expresspharma
February 05, 2021
Malaysia’s government said on Thursday it expects to complete its COVID-19 immunisation programme by February next year, covering 80 per cent of its population of about 32 million people.
New analysis backs safety, efficacy of AZ/Oxford COVID-19 jab pharmatimes
February 04, 2021
A primary analysis of late-stage trial data has backed the safety and efficacy of AstraZeneca/Oxford University's COVID-19 vaccine, with 100% protection against severe disease, hospitalisation and death.
AstraZeneca and UCL to collaborate on two immuno-oncology projects pharmatimes
February 04, 2021
British drugmaker and researchers from the UCL Division of Infection & Immunity will collaborate on two projects which will aim to contribute to the development of new cancer treatments.
Oxford Kept COVID-19 Vaccine Trial Volunteers in Dark About Dosing Error, Letter Shows expresspharma
February 04, 2021
The letter was signed by the trial’s chief investigator, Oxford professor Andrew J. Pollard, and sent to the trial subjects.
Verity Pharma and India’s SII apply to distribute AstraZeneca vaccine in Canada expresspharma
February 03, 2021
Verity Pharmaceuticals and Serum Institute of India (SII) have applied to distribute SII’s licensed version of AstraZeneca’s COVID-19 vaccine in Canada, potentially easing shortages as European manufacturing sites struggle to meet global demand.
AstraZeneca to Divest Viela Shareholding americanpharmaceuticalreview
February 02, 2021
AstraZeneca has agreed, subject to certain limited exceptions, to divest its 26.7% ownership in Viela Bio, as part of the proposed acquisition of Viela by Horizon Therapeutics.
AstraZeneca to supply 9 million more vaccine doses: EU expresspharma
February 02, 2021
AstraZeneca has agreed to supply 9 million additional doses of its coronavirus vaccine to the European Union during the first quarter, the bloc’s executive arm said Sunday.
South Africa’s first COVID-19 vaccine doses arrive by plane expresspharma
February 02, 2021
The vaccine shots will be checked over roughly 10 to 14 days before they will be distributed to the country’s nine provinces.
AstraZeneca COVID-19 Vaccine Recommended for use in the EU americanpharmaceuticalreview
February 01, 2021
AstraZeneca’s COVID-19 vaccine has been recommended for conditional marketing authorization (CMA) in the European Union (EU) for active immunization to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page